Fundies.
English

Segment disclosures

Company overview

Novo Integrated Sciences, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

6 dimension combinations 64 retained observations 17 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Health Care Services

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=NVOS:HealthCareServicesMember
PeriodValueUnitFiledEvidence
2023-09-01 – 2024-08-318297530 USD20241218Open filing evidence
2024-03-01 – 2024-05-312183334 USD20240719Open filing evidence
2023-09-01 – 2024-05-316331439 USD20240719Open filing evidence
2023-12-01 – 2024-02-292103595 USD20240415Open filing evidence
2023-09-01 – 2024-02-294148105 USD20240415Open filing evidence
2023-09-01 – 2023-11-302044510 USD20240122Open filing evidence
2022-09-01 – 2023-08-318226674 USD20241218Open filing evidence
2023-03-01 – 2023-05-312019869 USD20240719Open filing evidence
2022-09-01 – 2023-05-316075237 USD20240719Open filing evidence
2022-12-01 – 2023-02-282034154 USD20240415Open filing evidence
2022-09-01 – 2023-02-284055368 USD20240415Open filing evidence
2022-09-01 – 2022-11-302021213 USD20240122Open filing evidence
2021-09-01 – 2022-08-318397857 USD20231214Open filing evidence
2022-03-01 – 2022-05-312199889 USD20230717Open filing evidence
2021-09-01 – 2022-05-316253089 USD20230717Open filing evidence
2021-12-01 – 2022-02-281873577 USD20230526Open filing evidence
2021-09-01 – 2022-02-284053200 USD20230526Open filing evidence
2021-09-01 – 2021-11-302179623 USD20230524Open filing evidence
2020-09-01 – 2021-08-318857693 USD20230403Open filing evidence
2021-03-01 – 2021-05-312380974 USD20220913Open filing evidence
2020-09-01 – 2021-05-316612374 USD20220913Open filing evidence
2020-12-01 – 2021-02-282075894 USD20220413Open filing evidence
2020-09-01 – 2021-02-284231400 USD20220413Open filing evidence
2020-09-01 – 2020-11-302155506 USD20220118Open filing evidence
2019-09-01 – 2020-08-317860567 USD20220913Open filing evidence

Product Manufacturingand Development

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=NVOS:ProductManufacturingandDevelopmentMember
PeriodValueUnitFiledEvidence
2023-09-01 – 2023-11-301768458 USD20240122Open filing evidence
2022-09-01 – 2022-11-30790478 USD20240122Open filing evidence

Product Manufacturing And Development

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=NVOS:ProductManufacturingAndDevelopmentMember
PeriodValueUnitFiledEvidence
2024-03-01 – 2024-05-31968517 USD20240719Open filing evidence
2023-09-01 – 2024-05-313803971 USD20240719Open filing evidence
2023-12-01 – 2024-02-291066997 USD20240415Open filing evidence
2023-09-01 – 2024-02-292835455 USD20240415Open filing evidence
2023-03-01 – 2023-05-311273064 USD20240719Open filing evidence
2022-09-01 – 2023-05-312576196 USD20240719Open filing evidence
2022-12-01 – 2023-02-28512654 USD20240415Open filing evidence
2022-09-01 – 2023-02-281303132 USD20240415Open filing evidence
2022-09-01 – 2022-11-30790478 USD20230524Open filing evidence
2021-12-01 – 2022-02-28995646 USD20220413Open filing evidence
2021-09-01 – 2022-02-281977950 USD20220413Open filing evidence
2021-09-01 – 2021-11-30982304 USD20230524Open filing evidence
2020-09-01 – 2021-08-31447562 USD20220913Open filing evidence

Product Manufacturing And Devolopment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=NVOS:ProductManufacturingAndDevolopmentMember
PeriodValueUnitFiledEvidence
2023-03-01 – 2023-05-311273064 USD20230717Open filing evidence
2022-09-01 – 2023-05-312576196 USD20230717Open filing evidence
2022-12-01 – 2023-02-28512654 USD20230526Open filing evidence
2022-09-01 – 2023-02-281303132 USD20230526Open filing evidence
2022-03-01 – 2022-05-3111651994 USD20230717Open filing evidence
2021-09-01 – 2022-05-3113629944 USD20230717Open filing evidence
2021-12-01 – 2022-02-28995646 USD20230526Open filing evidence
2021-09-01 – 2022-02-281977950 USD20230526Open filing evidence

Product Sales

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=NVOS:ProductSalesMember
PeriodValueUnitFiledEvidence
2023-09-01 – 2024-08-314918577 USD20241218Open filing evidence
2022-09-01 – 2023-08-314335645 USD20241218Open filing evidence
2021-09-01 – 2022-08-313336899 USD20231214Open filing evidence
2022-03-01 – 2022-05-3111651994 USD20220913Open filing evidence
2021-09-01 – 2022-05-3113629944 USD20220913Open filing evidence
2020-09-01 – 2021-08-31447562 USD20230403Open filing evidence

Corporate

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember
PeriodValueUnitFiledEvidence
2023-09-01 – 2024-08-3178250 USD20241218Open filing evidence
2023-09-01 – 2024-05-3178251 USD20240719Open filing evidence
2023-09-01 – 2024-02-2978250 USD20240415Open filing evidence
2023-09-01 – 2023-11-3078250 USD20240122Open filing evidence
2022-09-01 – 2023-08-319700 USD20241218Open filing evidence
2022-09-01 – 2023-05-31617289 USD20240719Open filing evidence
2022-12-01 – 2023-02-289701 USD20240415Open filing evidence
2022-09-01 – 2023-02-28617289 USD20240415Open filing evidence
2022-09-01 – 2022-11-30607589 USD20240122Open filing evidence
2021-09-01 – 2022-08-313181 USD20231214Open filing evidence